Please login to the form below

Not currently logged in
Email:
Password:

Marstacimab

This page shows the latest Marstacimab news and features for those working in and with pharma, biotech and healthcare.

Pfizer doses first patient in investigational haemophilia drug trial

Pfizer doses first patient in investigational haemophilia drug trial

It will compare marstacimab to a run-in period on replacement therapy with VIII or IX clotting factor, respectively, or bypass therapy. ... Marstacimab offers a new way of treating haemophilia that does not rely on replacing factor VIII or factor IX.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...